NCT06787885View on ClinicalTrials.gov

Evaluation of Efficacy and Safety Parameters of Different Antibiotics Regimens for Management of Empyema

NARecruitingINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

May 1, 2025

Conditions

Empyema, Pleural

Interventions

DRUG

Levofloxacin + clindamycin

Group 1

DRUG

Levofloxacin + cefipime

Group 2

DRUG

Moxifloxacin + meronam

Group 3

Trial Locations (1)

Unknown

RECRUITING

Fayoum University hospital, Al Fayyum

All Listed Sponsors

lead

Fayoum University

OTHER